About Volcano Corporation
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(TM) tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters. Currently, more than 3,500 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at http://www.volcanocorp.com.
This press release contains forward-looking statements within the
meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any
statements in this release regarding Volcano's business that are not
historical facts may be considered forward-looking statements, including
statements regarding the commercial prospects for, or potential customer
use of, the PrimeWire Pressure Guidewire and the s5-FFR Option.
Forward-looking statements involve risks and uncertainties and are based on
management's current expectations. Actual results could differ materially
from these forward-looking sta
|SOURCE Volcano Corporation|
Copyright©2008 PR Newswire.
All rights reserved